Clinical Trial Update: Study of an Investigational Pentavalent Meningococcal ABCYW Vaccine in Adults and Adolescents [Phase 1, Phase 2]

View source ↗

Summary

This document notes the completion of a Phase 1/Phase 2 trial of an investigational pentavalent meningococcal ABCYW vaccine in adults and adolescents; no effica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Disease

Drugs mentioned

• pentavalent meningococcal ABCYW vaccine (investigational)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Meningococcal Immunisation, Healthy Volunteers | Phase 1, Phase 2 | Status: COMPLETED